Primerica, Inc. Form 8-K Summary
Business Context and Reporting Period
Primerica, Inc. (PRI), a Delaware corporation, filed this Current Report on Form 8-K on February 11, 2026. The filing announces the results of operations for the quarter ended December 31, 2025. The company is incorporated in Delaware and maintains its principal executive offices in Duluth, Georgia.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that these results have been announced and directs investors to attached exhibits for detailed figures.
The company reports both GAAP and Non-GAAP financial measures. Key Non-GAAP metrics defined in the filing include:
- Adjusted direct premiums and other ceded premiums (net of IPO coinsurance transactions).
- Adjusted operating revenues, income before taxes, and net operating income (excluding investment gains/losses, fair value mark-to-market adjustments, and specific non-recurring items).
- Diluted adjusted operating earnings per share.
- Adjusted stockholders' equity (excluding net unrealized investment gains/losses and discount rate differences).
Material Changes and Non-GAAP Adjustments
The filing details specific exclusions made to derive Non-GAAP measures to ensure meaningful period-over-period comparisons:
- Investment Volatility: Excludes investment gains/losses, credit impairments, and mark-to-market adjustments to eliminate fluctuations caused by market pricing and timing.
- Non-Recurring Items: Excludes insurance proceeds from a Representation and Warranty policy related to the 2021 acquisition of e-TeleQuote Insurance, Inc.
- Restructuring: Excludes corporate restructuring charges associated with the 2024 decision to exit the senior health business.
- Tax Effects: Excludes tax effects of pre-tax operating adjustments and the 2024 valuation allowance for e-TeleQuote's state net operating losses.
- Equity Adjustments: Excludes unrealized gains/losses on available-for-sale securities and differences in future policy benefits due to discount rate changes.
Guidance, Outlook, and Risks
The filing text does not contain specific forward-looking guidance, management commentary on future performance, or a detailed discussion of risks and contingencies beyond the standard disclosures regarding the limitations of Non-GAAP measures. The company states that management uses these Non-GAAP measures for financial planning and performance evaluation.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q4 2025 revenue, earnings, and cash flow figures.
- Examine Exhibit 99.2 for supplemental financial information and the reconciliation of GAAP to Non-GAAP measures.
- Verify the impact of the 2024 senior health business exit on current operating results.
- Assess the magnitude of investment gains/losses and mark-to-market adjustments excluded from Non-GAAP results.
- Confirm the status of IPO coinsurance transactions and their declining impact on adjusted premiums.